Khalifa University will host the President of Global Research and Development for French multinationalpharmaceutical company Sanofi Dr. Elias Zerhouni as part of the University’s Distinguished Speakers Series being held February 28 2016 at the Emirates Center for Strategic Studies and Research (ECSSR). Dr. Zerhouni is also a member of Khalifa University’s Board of Trustees and he will speak to the public about biomedical research and development and its current and future directions.
Biomedical research refers to the field of study that aids and supports the development of knowledge in the field of medicine including clinical research and in the case of biomedical engineering the combination of engineering and medical and biological sciences to advance health care treatment including diagnosis monitoring and therapy.
In the past Dr. Zerhouni who also served as Director of the United States National Institutes of Health has spoken of the challenges facing the pharmaceutical and biomedical industries in particular the needs of patients who are demanding improved health care services from providers and the concerns of providers who are facing higher health care costs in order to pay for medical innovation.
Currently Khalifa University offers a Bachelor’s Degree in Biomedical Engineering and an option to specialize in Biomedical Engineering at the PhD level.
The lecture will begin at 7:30 pm on Sunday February 28 2016 and is open to the public. To RSVP please email firstname.lastname@example.org.
|Download Official KU Press Release – English||
Ã™â€žÃ™â€žÃ™â€¦Ã˜Â´Ã˜Â§ÃšÂ¾Ã˜Â¯Ã˜Â© Ã™Ë†Ã˜Â§Ã™â€žÃ˜ÂªÃ™â€ Ã˜Â²Ã›Å’Ã™â€ž Ã˜Â¨Ã˜Â§Ã™â€žÃ™â€žÃ˜ÂºÃ˜Â© Ã˜Â§Ã™â€žÃ˜Â¹Ã˜Â±Ã˜Â¨Ã›Å’Ã˜Â©